You are here

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Last updated on May 11, 2018

FOR MORE INFORMATION
Study Location
Tucson, Arizona, 85404 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Acute Myeloid Leukemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Treated by Mylotarg

- Provide ICF

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Treated by Mylotarg

- Provide ICF

NCT00161668
Pfizer
Completed
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
Prospective Observational Study of Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
This study is designed to assess the safety of Mylotarg therapy in routine practice.
Not Provided
Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Acute Myeloid Leukemia
Drug: Mylotarg
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
500
Not Provided
Not Provided

Inclusion Criteria:

  • Treated by Mylotarg
  • Provide ICF
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00161668
0903X-100847
Not Provided
Not Provided
Not Provided
Not Provided
Wyeth is now a wholly owned subsidiary of Pfizer
Not Provided
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
March 2007

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now